Ardelyx (ARDX), Raymond James up Price Target, Citigroup Joins the Party.
Wall Street Cozy's up to Ardelyx After New Guidance.
On January 8th, Mike Raab, President and Chief Executive Officer stated, "We consistently grew sales of...
Is David Dodd on to his Next Billion Dollar Payday for Shareholders?
Huge News: Gedeptin® Therapy Demonstrated Safety, Stabilization and Shrinkage of Treated Tumors.
GeoVax (GOVX) Completes Patient Enrollment for Head & Neck Cancer Drug, Gedeptin.®
David...
Citius Pharmaceuticals, Inc. (CTXR) Reports Fiscal Full Year 2023 Financial Results and Provides Business...
Mino-Lok® Pivotal Phase 3 trial enrollment completed; topline data expected 2Q 2024
LYMPHIR™ BLA resubmission on track for early 2024
CRANFORD, N.J., Jan. 2, 2024 /PRNewswire/ -- Citius Pharmaceuticals,...
Pharmather (PHRRF) Has Officially Broken Out.
Read Corporate Presentation Today.
Pharmather (PHRRF) which we gave a 'heads-up,' because looked like it was about to break above resistance last week, has soundly...
Post Reverse Split Mania!
Now Wait a Minute, Aren't Stocks That do Reverse Splits Supposed go Down and Stay Down?
First our client LQR House (LQR) goes from $1.00...
Adding Geovax (GOVX) to 2024 Biotech Watch List.
GEOVAX (GOVX) $0.32
We added this to the Watch List earlier in the week and then AFTER speaking to CEO David Dodd and the Head...
LQR House (LQR) Commits to Postpone Public Offerings for the Foreseeable Future.
LQR House Initiates Warrants Cancellation and Commits to Postpone Public Offerings for the Foreseeable Future
MIAMI BEACH, FL / ACCESSWIRE / December 20, 2023 / LQR...
PharmaTher (PHRRF) Breaks Above Resistance.
We're now up 325% in just Under a Year. Last "big" News was Receiving a Priority Original Abbreviated New Drug Application, for KETARX™ (Ketamine)...
GeoVax (GOVX) Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox.
ATLANTA, GA, Dec. 19, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and...
Ardelyx (ARDX) Firmly Above Resistance.
Were not traders and we don't do technical analysis, but we could see this coming from a mile away. Next stop $9.00 and then...
Latest article
Party Time at UniQure (QURE)! From $8.86 to $47.21, up 432%.
I. No Bells, No Baskets.UniQure (QURE) $47 up Huge. Still Not Out Of The Woods!II.Replimune (REPL) $11.23. Gains 28% in Sympathy with UniQure. We...
Adding Bavarian Nordic (BVRNY) $8.91, to Watch List.
Bavarian Nordic Lands $106 Million Contract for its Smallpox/Mpox Vaccine!
Were Back for the Third Time!
LIVE QUOTE
PREVIOUS WRITEUPS
Aug 27, 2025: Our 4th Billion Dollar Takeover!...
Fusion Energy Starter.
VC-Funded Fusion Energy Companies
"The fastest way to deploy fusion and I believe one of my forecasts is we will replace every coal and natural...
